Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative age-Related macular degeneration (TIGER): a European randomised controlled surgical trial.

Jackson, Timothy (Primary Investigator)
Wang, Yanzhong (Co-Investigator)
academic, affiliated (Co-Investigator)

Project: Research

Acronym	TIGER
Status	Active
Effective start/end date	1/09/2020 → 31/08/2025

Collaborative partners

King's College London (lead)
Queen's University Belfast
University of Bristol
KCH King's College Hospital NHS Foundation Trust

Funding

Fight for Sight: £1,799,779.00